
Cynata
An Australian clinical-stage stem cell and regenerative medicine company focused on the development of therapies based on a proprietary therapeutic stem cell platform technology.
Market cap
$21.9m
Enterprise value
$15m
Share price
AUD0.15 CYP.AX
Authorizing premium user...